Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 172648-19-0 | MDL No. : | MFCD09750272 |
Formula : | C7H6BrN3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SRDOBLPQJXFKIE-UHFFFAOYSA-N |
M.W : | 228.05 | Pubchem ID : | 10823202 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.72 |
TPSA : | 61.8 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.27 cm/s |
Log Po/w (iLOGP) : | 0.99 |
Log Po/w (XLOGP3) : | 0.59 |
Log Po/w (WLOGP) : | 1.06 |
Log Po/w (MLOGP) : | 0.42 |
Log Po/w (SILICOS-IT) : | 2.03 |
Consensus Log Po/w : | 1.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.11 |
Solubility : | 1.75 mg/ml ; 0.00768 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.46 |
Solubility : | 7.88 mg/ml ; 0.0346 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.23 |
Solubility : | 0.135 mg/ml ; 0.000592 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.01 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1207174-85-3 ]
7-Bromo-3H-imidazo[4,5-b]pyridine
Similarity: 0.70
[ 28279-49-4 ]
6-Bromo-4H-imidazo[4,5-b]pyridine
Similarity: 0.68
[ 28279-41-6 ]
6-Bromo-5-methyl-1H-imidazo[4,5-b]pyridine
Similarity: 0.66
[ 540516-28-7 ]
2-(Hydroxymethyl)-5-bromobenzimidazole
Similarity: 0.64
[ 20223-87-4 ]
4-Bromo-2-methyl-1H-benzimidazole
Similarity: 0.61
[ 4856-97-7 ]
(1H-Benzoimidazol-2-yl)methanol
Similarity: 0.65
[ 540516-28-7 ]
2-(Hydroxymethyl)-5-bromobenzimidazole
Similarity: 0.64
[ 20034-00-8 ]
(5-Nitro-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.61
[ 79707-11-2 ]
2-Methylimidazo[1,2-a]pyridin-8-ol
Similarity: 0.59
[ 39811-07-9 ]
(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.59
[ 97640-15-8 ]
3H-Imidazo[4,5-b]pyridine-2-carboxylic acid
Similarity: 0.80
[ 1207174-85-3 ]
7-Bromo-3H-imidazo[4,5-b]pyridine
Similarity: 0.70
[ 28279-49-4 ]
6-Bromo-4H-imidazo[4,5-b]pyridine
Similarity: 0.68
[ 1019108-05-4 ]
3H-Imidazo[4,5-b]pyridine-5-carboxylic acid
Similarity: 0.67
[ 28279-41-6 ]
6-Bromo-5-methyl-1H-imidazo[4,5-b]pyridine
Similarity: 0.66